FDA approval for the Retain product has been delayed.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• ICCC →

  Japanese nonprofit organisation

  Nothing else this week.

Related events

• FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.Thu 15:32
• FDA issued a partial clinical hold on trials involving Biohaven Ltd. on September 11, 2026.Sep 12
• The FDA placed a clinical hold on the IND application for the company Aardvark.Jul 30
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• Unregulated products are bypassing official government approval processes.Aug 12